Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma
Clinical trial NCT01542918 · COMPLETED
Trial details
- NCT number
- NCT01542918
- Sponsor
- James Rubenstein
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-17
- Primary completion
- 2016-04-07
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.